U.S. health officials have expanded approval of a drug that boosts libido in women who report stress due to a low sex drive.
The U.S. Food and Drug Administration has sent warning letters to four major retailers for continuing to sell baby formula ...
The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...
Zoliflodacin is the first of a new class of antibiotics, called spiropyrimidinetriones, that have activity against Neisseria ...
The U.S. Food and Drug Administration has approved Daiichi Sankyo's therapy in combination with Roche's drug for the ...
The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...
Supplements aren’t reviewed for safety and effectiveness, but disclaimers about health benefits are required on products.
Walmart, Target, Kroger and Albertsons accused of continuing to sell “adulterated” infant formula linked to an outbreak that ...
If the FDA ceases to be a predictable source of regulatory guidance, then China will gain a significant advantage in the race ...
The FDA has “proactively” granted Johnson & Johnson a coveted speedy review under the Commissioner’s National Priority ...
The B-cell depleting therapy is indicated for adults with generalized myasthenia gravis and anti-acetylcholine receptor or anti-muscle-specific tyrosine kinase antibodies.
The FDA has qualified AI-Based Histologic Measurement of NASH, or AIM-NASH — the first AI drug development tool — to assist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback